MiR-17-92 cluster: An apoptosis inducer or proliferation enhancer

Molecular and Cellular Biochemistry

Volumn 380, Issue 1-2, 2013, Pages 229-238

  Ranji, Najmeh ^a   Sadeghizadeh, Majid ^b   Shokrgozar, Mohammad Ali ^c   Bakhshandeh, Behnaz ^d   Karimipour, Morteza ^c   Amanzadeh, Amir ^c   Azadmanesh, Keyhan ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Antigen induced cell death; Clonal expansion; IL 2 induction; miR 17 92 cluster; Na ve CD4+T cells

Indexed keywords

CD3 ANTIBODY; DUAL SPECIFICITY PHOSPHATASE; INTERLEUKIN 2; JANUS KINASE; MICRORNA; MICRORNA 17 92; MITOGEN ACTIVATED PROTEIN KINASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE GAMMA; PIK3R3 PROTEIN; PROTEIN ANTIBODY; PROTEIN KINASE B; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ALGORITHM; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; STAINING; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; E2F TRANSCRIPTION FACTORS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; JANUS KINASES; LYMPHOCYTE ACTIVATION; MALE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; MULTIGENE FAMILY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAT TRANSCRIPTION FACTORS;

EID: 84879800461     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-013-1678-7     Document Type: Article

References (52)

1. Xue Q, Guo ZY, Li W, Wen WH, Meng YL, Jia LT, Wang J, Yao LB, Jin BQ, Wang T, Yang AG (2011) Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c. Mol Immunol 48:592-599. doi: 10.1016/j.molimm.2010.10.021
2. Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O (2001) CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 15:935-945. doi: S1074-7613(01)00244-8
3. Liwski RS, Chase JC, Baldridge WH, Sadek I, Rowden G, West KA (2006) Prolonged costimulation is required for naive T cell activation. Immunol Lett 106:135-143. doi: 10.1016/j.imlet.2006.05.003
4. Garcon F, Patton DT, Emery JL, Hirsch E, Rottapel R, Sasaki T, Okkenhaug K (2008) CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer. Blood 111:1464-1471. doi: 10.1182/blood-2007-08-108050
5. Eder AM, Dominguez L, Franke TF, Ashwell JD (1998) Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells. J Biol Chem 273:28025-28031
6. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V, Macino G (2010) An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 115:265-273. doi: 10.1182/blood-2009-06-225987
7. Fung MM, Rohwer F, McGuire KL (2003) IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells. Cell Signal 15:625-636. doi: S0898656803000032
8. +T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J Immunol 171:61-68
9. Zhang S, Zhang H, Zhao J (2009) The role of CD4 T cell help for CD8 CTL activation. Biochem Biophys Res Commun 384:405-408. doi: 10.1016/j.bbrc.2009.04. 134
10. +T cell responses. PLoS ONE 4:e7766. doi: 10.1371/journal.pone.0007766
11. +T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 104:775-780. doi: 10.1182/blood-2003-12-4355
12. Yang JC, Sherry RM, Steinberg SM, Topalian SL, Schwartzentruber DJ, Hwu P, Seipp CA, Rogers-Freezer L, Morton KE, White DE, Liewehr DJ, Merino MJ, Rosenberg SA (2003) Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer. J Clin Oncol 21:3127-3132. doi: 10.1200/JCO.2003.02.122
13. +T cell count predicts response to subcutaneous recombinant interleukin-2. Clin Infect Dis 37:e115-e120. doi: 10.1086/378293
14. Lodish HF, Zhou B, Liu G, Chen CZ (2008) Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8:120-130. doi: 10.1038/nri2252
15. Kanellopoulou C, Monticelli S (2008) A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol 18:79-88. doi: 10.1016/j.semcancer.2008.01.002
16. Sonkoly E, Stahle M, Pivarcsi A (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18:131-140. doi: 10.1016/j.semcancer.2008.01.005
17. Lindsay MA (2008) MicroRNAs and the immune response. Trends Immunol 29:343-351. doi: 10.1016/j.it.2008.04.004
18. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6:259-269. doi: 10.1038/nrc1840
19. Bakhshandeh B, Hafizi M, Ghaemi N, Soleimani M (2012) Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. Biotechnol Lett 34:1579-1587. doi: 10.1007/s10529-012-0934-3
20. Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald HA, Reinhart TA, Martinson J, Lotze MT, Marincola FM, Wang E, Fujita M, Okada H (2010) miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. J Transl Med 8:17. doi: 10.1186/1479-5876-8-17
21. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6:60. doi: 10.1186/1476-4598-6-60
22. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B, Meijer GA (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101:707-714. doi: 10.1038/sj.bjc.6605037
23. Olive V, Jiang I, He L (2010) mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int J Biochem Cell Biol 42:1348-1354. doi: 10.1016/j.biocel.2010.03.004
24. Shu L, Yin W, Zhuang H, Hua Z (2006) Comparison of gene expression profiles in mouse primary T cells under normal and prolonged activation. Blood Cells Mol Dis 37:64-75. doi: 10.1016/j.bcmd.2006.04.002
25. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38(Suppl):S8-S13. doi: 10.1038/ng1798
26. Bakhshandeh B, Soleimani M, Hafizi M, Paylakhi SH, Ghaemi N (2012) microRNA signature associated with osteogenic lineage commitment. Mol Biol Rep 39:7569-7581. doi: 10.1007/s11033-012-1591-2
27. Bakhshandeh B, Soleimani M, Paylakhi SH, Ghaemi N (2012) A microRNA signature associated with chondrogenic lineage commitment. J Genet 91:171-182
28. Chang X, Liu F, Wang X, Lin A, Zhao H, Su B (2011) The kinases MEKK2 and MEKK3 regulate transforming growth factor-beta-mediated helper T cell differentiation. Immunity 34:201-212. doi: 10.1016/j.immuni.2011.01.017
29. Kane LP, Lin J, Weiss A (2002) It's all Rel-ative: NF-kappaB and CD28 costimulation of T-cell activation. Trends Immunol 23:413-420
30. Juntilla MM, Wofford JA, Birnbaum MJ, Rathmell JC, Koretzky GA (2007) Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. Proc Natl Acad Sci USA 104:12105-12110. doi: 10.1073/pnas.0705285104
31. Oda K, Asao H, Higuchi M, Tanaka N, Moffatt S, Nakamura M, Tabayashi K, Sugamura K (1997) Induction of IL-1 beta-converting enzyme-independent apoptosis by IL-2 in human T cell lines. Int Immunol 9:1303-1310
32. Kovanen PE, Young L, Al-Shami A, Rovella V, Pise-Masison CA, Radonovich MF, Powell J, Fu J, Brady JN, Munson PJ, Leonard WJ (2005) Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. Int Immunol 17:1009-1021. doi: 10.1093/intimm/dxh283
33. Liao W, Lin JX, Leonard WJ (2011) IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598-604. doi: 10.1016/j.coi.2011.08.003
34. Crispin JC, Apostolidis SA, Finnell MI, Tsokos GC (2011) Induction of PP2A Bbeta, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc Natl Acad Sci USA 108:12443-12448. doi: 10.1073/pnas.1103915108
35. Hieronymus T, Blank N, Gruenke M, Winkler S, Haas JP, Kalden JR, Lorenz HM (2000) CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes. Cell Death Differ 7:538-547. doi: 10.1038/sj.cdd.4400684
36. Devireddy LR, Green MR (2003) Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor. Mol Cell Biol 23:4532-4541
37. Fleischer A, Duhamel M, Lopez-Fernandez LA, Munoz M, Rebollo MP, Alvarez-Franco F, Rebollo A (2007) Cascade of transcriptional induction and repression during IL-2 deprivation-induced apoptosis. Immunol Lett 112:9-29. doi: 10.1016/j.imlet.2007.06.004
38. Razumilava N, Bronk SF, Smoot RL, Fingas CD, Werneburg NW, Roberts LR, Mott JL (2012) miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 55:465-475. doi: 10.1002/hep.24698
39. Petrocca F, Vecchione A, Croce CM (2008) Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68:8191-8194. doi: 10.1158/0008-5472.CAN-08-1768
40. Cloonan N, Brown MK, Steptoe AL, Wani S, Chan WL, Forrest AR, Kolle G, Gabrielli B, Grimmond SM (2008) The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9:R127. doi: 10.1186/gb-2008-9-8- r127
41. Jiang S, Li C, Olive V, Lykken E, Feng F, Sevilla J, Wan Y, He L, Li QJ (2011) Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood 118:5487-5497. doi: 10.1182/blood-2011-05-355644
42. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839-843. doi: 10.1038/nature03677
43. Woods K, Thomson JM, Hammond SM (2007) Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282:2130-2134. doi: 10.1074/jbc.C600252200
44. Yu XF, Zou J, Bao ZJ, Dong J (2011) miR-93 suppresses proliferation and colony formation of human colon cancer stem cells. World J Gastroenterol 17:4711-4717. doi: 10.3748/wjg.v17.i42.4711
45. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17:F19-F36. doi: 10.1677/ERC-09-0184
46. Fang L, Zhang HB, Li H, Fu Y, Yang GS (2012) miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells. Radiol Oncol 46:233-241. doi: 10.2478/v10019-012-0025-z
47. Beadling C, Smith KA (2002) DNA array analysis of interleukin-2-regulated immediate/early genes. Med Immunol 1:2
48. Deane JA, Trifilo MJ, Yballe CM, Choi S, Lane TE, Fruman DA (2004) Enhanced T cell proliferation in mice lacking the p85beta subunit of phosphoinositide 3-kinase. J Immunol 172:6615-6625
49. Kok K, Geering B, Vanhaesebroeck B (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci 34:115-127. doi: 10.1016/j.tibs.2009.01.003
50. Fletcher J, Starr R (2005) The role of suppressors of cytokine signaling in thymopoiesis and T cell activation. Int J Biochem Cell Biol 37:1774-1786. doi: 10.1016/j.biocel.2005.04.005
51. Sporri B, Kovanen PE, Sasaki A, Yoshimura A, Leonard WJ (2001) JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 97:221-226
52. Xiao C, Rajewsky K (2009) microRNA control in the immune system: basic principles. Cell 136:26-36. doi: 10.1016/j.cell.2008.12.027